학술논문

A PERSONALIZED MEDICINE EX VIVO TEST TO PREDICT CLINICAL RESPONSE TO FIRST LINE INDUCTION THERAPY WITH IDARUBICIN AND CYTARABINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA